Mingjie Lu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 5
-
- RNA modifications and cancer 1
- Ubiquitin and proteasome pathways 1
- Co-authors
- Wei Zhu (3 shared papers)Yingjie Wang (1 shared paper)Dong Yang (1 shared paper)Zhaowei Liu (1 shared paper)Hao Wu (1 shared paper)Yongqian Shu (1 shared paper)Min Huang (1 shared paper)Peng Cao (1 shared paper)
- Journals
- Frontiers in Bioengineering and Biotechnology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Frontiers in Immunology (1 paper)Academic Radiology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Mingjie Lu
25 papers receiving 589 citations
Peers
Comparison fields: 5 of 121
- Cancer Research 141
- Health Informatics 8
- Oncology 87
- General Dentistry 5
- Molecular Biology 198
Countries citing papers authored by Mingjie Lu
This map shows the geographic impact of Mingjie Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjie Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjie Lu more than expected).
Fields of papers citing papers by Mingjie Lu
This network shows the impact of papers produced by Mingjie Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjie Lu. The network helps show where Mingjie Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingjie Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 92 | |
| 2 | 2023 | 86 | |
| 3 | 2023 | 60 | |
| 4 | 2022 | 60 | |
| 5 | 2021 | 44 | |
| 6 | 2018 | 40 | |
| 7 | 2016 | 37 | |
| 8 | Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44. | 2017 | 33 |
| 9 | 2016 | 31 | |
| 10 | 2023 | 23 | |
| 11 | 2021 | 22 | |
| 12 | 2017 | 15 | |
| 13 | 2024 | 11 | |
| 14 | 2024 | 7 | |
| 15 | 2022 | 7 | |
| 16 | 2016 | 7 | |
| 17 | 2016 | 5 | |
| 18 | 2024 | 4 | |
| 19 | 2024 | 3 | |
| 20 | 2022 | 3 |
About Mingjie Lu
Mingjie Lu is a scholar working on Oncology, Molecular Biology, Physiology, Cancer Research and Endocrine and Autonomic Systems, having authored 26 papers that have together received 597 indexed citations. Recurring topics across this work include Spaceflight effects on biology (2 papers), Computational Drug Discovery Methods (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Circadian rhythm and melatonin (2 papers), MicroRNA in disease regulation (2 papers), Virus-based gene therapy research (1 paper), RNA modifications and cancer (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (141 citations), Health Informatics (8 citations), Oncology (87 citations), General Dentistry (5 citations) and Molecular Biology (198 citations). Mingjie Lu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wei Zhu, Yingjie Wang, Dong Yang, Zhaowei Liu, Hao Wu, Yongqian Shu, Min Huang, Peng Cao, Ping Liu and Shidai Jin. Their work appears in journals such as Frontiers in Bioengineering and Biotechnology, Journal for ImmunoTherapy of Cancer, Frontiers in Cell and Developmental Biology, Frontiers in Immunology and Academic Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.